Based on this finding, we next tested whether doxorubicin treatment may also trigger DINO expression in the HPV-negative C33A cervical carcinoma line which expresses the DNA binding-defective TP53 R273H mutant (45, –, 47). The gene discussed is TP53; the disease is cervical carcinoma.